{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:02:40Z","timestamp":1769004160502,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.amjcard.2006.02.020","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T12:14:41Z","timestamp":1143807281000},"page":"23-29","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S1","title":["Potential for Drug\u2013Drug Interactions in Patients Taking Analgesics for Mild-to-Moderate Pain and Low-Dose Aspirin for Cardioprotection"],"prefix":"10.1016","volume":"97","author":[{"given":"J. Michael","family":"Gaziano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2006.02.020_bib1","series-title":"Heart Disease and Stroke Statistics\u20142005 Update","year":"2005"},{"key":"10.1016\/j.amjcard.2006.02.020_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events","volume":"136","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.020_bib4","first-page":"74","article-title":"Physician advice and individual behaviors about cardiovascular disease risk reduction","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjcard.2006.02.020_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2006.02.020_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.0000087593.07533.9B","article-title":"Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs","volume":"108","author":"Kurth","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.020_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","article-title":"Effect of ibuprofen on cardioprotective effect of aspirin","volume":"361","author":"MacDonald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.02.020_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/hh2001.098351","article-title":"Prostaglandin H synthase and vascular function","volume":"89","author":"Davidge","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2006.02.020_bib10","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib11","unstructured":"National Institutes of Health. Use of non-steroidal anti-inflammatory drugs suspended in large Alzheimer\u2019s disease prevention trial. December 20, 2004. Available at: http:\/\/www.nih.gov\/news\/pr\/dec2004\/od-20.htm. Accessed October 20, 2005."},{"key":"10.1016\/j.amjcard.2006.02.020_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib13","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1001\/archinte.160.20.3123","article-title":"An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease","volume":"160","author":"Hebert","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00001648-200007000-00004","article-title":"Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women","volume":"11","author":"Garc\u00eda Rodr\u00edguez","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.amjcard.2006.02.020_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2006.02.020_bib17","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.020_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.020_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000084501.48570.F6","article-title":"Randomized, double-blind, placebo-controlled, international trial of the oral IIb\/IIIa antagonist lotrafiban in coronary and cerebrovascular disease","volume":"108","author":"Topol","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.020_bib20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib21","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.162.10.1099","article-title":"Nonsteroidal anti-inflammatory drug use and acute myocardial infarction","volume":"162","author":"Solomon","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127000004001005","article-title":"Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers","volume":"40","author":"Van Hecken","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2006.02.020_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archinte.162.10.1105","article-title":"Lower risk of thromboembolic cardiovasular events with naproxen among patients with rheumatoid arthritis","volume":"162","author":"Watson","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(02)07370-1","article-title":"Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease","volume":"359","author":"Ray","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.02.020_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archinte.163.4.481","article-title":"Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly","volume":"163","author":"Mamdani","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(03)12560-3","article-title":"Parsing an enigma","volume":"361","author":"FitzGerald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.02.020_bib27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2003.08.064","article-title":"The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin","volume":"43","author":"Kimmel","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.020_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clinthera.2005.01.011","article-title":"Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers","volume":"27","author":"Cryer","year":"2005","journal-title":"Clin Ther"},{"issue":"suppl 26","key":"10.1016\/j.amjcard.2006.02.020_bib29","first-page":"18","article-title":"Epidemiology of NSAID induced gastrointestinal complications","volume":"26","author":"Singh","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjcard.2006.02.020_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs","volume":"123","author":"Silverstein","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS Study: a randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.020_bib32","first-page":"2398","article-title":"Reporting of 6-month vs 12-month data in a clinical trial of celecoxib","volume":"286","author":"Hrachovec","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.020_bib33","unstructured":"Lu HL. Statistical reviewer briefing document for the Advisory Committee. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3677b1_04_stats.doc. Accessed April 3, 2006."},{"key":"10.1016\/j.amjcard.2006.02.020_bib34","first-page":"2398","article-title":"Reporting of 6-month vs 12-month data in a clinical trial of celecoxib","volume":"286","author":"Wright","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.020_bib35","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib36","unstructured":"US Food and Drug Administration. FDA public health advisory: safety of Vioxx. September 30, 2004. Available at: http:\/\/www.fda.gov\/cder\/drug\/infopage\/vioxx\/PHA_vioxx.htm. Accessed October 20, 2005."},{"key":"10.1016\/j.amjcard.2006.02.020_bib37","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib38","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","article-title":"Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs","volume":"330","author":"Hippisley-Cox","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2006.02.020_bib39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archinte.165.9.978","article-title":"Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs","volume":"165","author":"Johnsen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.020_bib40","series-title":"FDA announces series of changes to the class of marketed non-steroidal anti-inflammatory drugs (NSAIDs)","year":"2005"},{"key":"10.1016\/j.amjcard.2006.02.020_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA"},{"issue":"suppl 5","key":"10.1016\/j.amjcard.2006.02.020_bib42","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1086\/317520","article-title":"Mechanism of action of acetaminophen","volume":"31","author":"Botting","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjcard.2006.02.020_bib43","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.amjcard.2006.02.020_bib44","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjcard.2006.02.020_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00045391-200007020-00005","article-title":"The role of analgesics in the management of osteoarthritis pain","volume":"7","author":"Brandt","year":"2000","journal-title":"Am J Ther"},{"key":"10.1016\/j.amjcard.2006.02.020_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM199107113250203","article-title":"Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee","volume":"325","author":"Bradley","year":"1991","journal-title":"N Engl J Med"},{"issue":"suppl 6","key":"10.1016\/j.amjcard.2006.02.020_bib47","first-page":"S205","article-title":"The management of persistent pain in older persons","volume":"50","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjcard.2006.02.020_bib48","series-title":"Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis","year":"2002"},{"key":"10.1016\/j.amjcard.2006.02.020_bib49","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906002189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906002189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T22:22:02Z","timestamp":1683411722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914906002189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0002914906002189"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2006.02.020","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}